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A B S T R A C T   
Background: Millions of individuals worldwide, particularly in Bangladesh, are exposed to arsenic, mainly 
through drinking water from tube wells. Arsenic is a reproductive toxicant, but there is limited knowledge of 
whether it influences pubertal development. 
Objectives: We evaluated the association between prenatal arsenic exposure and age at menarche. 
Methods: This prospective study was based on data from two studies conducted in Matlab, Bangladesh—the 
Maternal and Infant Nutrition Interventions in Matlab (MINIMat) trial and the Health Consequences of Arsenic in 
Matlab (AsMat) study. We included 809 MINIMat girls who participated in assessing age at menarche from July 
2016 to June 2017 and had prenatal arsenic exposure data through the AsMat study via measurements in tube 
well water used by the mothers during pregnancy. The exposure was categorized into <10, 10–49, 50–99, 
100–199, and ≥200 µg/L. We used Kaplan-Meier and Cox proportional hazards analyses with adjustment for 
potential confounders to evaluate the association between arsenic exposure and age at menarche. The results 
were presented by adjusted hazards ratio (aHR) with a 95% confidence interval (CI). 
Results: The median arsenic concentration in tube well water consumed by pregnant women was 80 µg/L 
(interquartile range 2–262 µg/L), and 55% drank water with concentrations above Bangladesh’s acceptable value 
of 50 µg/L. The median age at menarche was 13.0 years. The unadjusted analysis revealed 3.2 months delay in 
menarche for girls exposed to arsenic concentrations ≥200 µg/L compared with the girl exposed to arsenic 
concentrations <10 µg/L. Girls exposed to the same higher arsenic concentrations were 23% (aHR 0.77, 95% CI: 
0.63–0.95) less likely to have reached menarche than girls exposed to low arsenic concentrations. 
Conclusions: Increased levels of prenatal arsenic exposure were associated with older age at menarche. This delay 
may indicate endocrine disruptions that could potentially result in adverse health consequences in later life. This 
finding, along with other severe adverse health reinforces the need for arsenic mitigation at the population level.   
1. Introduction 
Puberty is the transition from childhood to the attainment of mature 
reproductive functions. It is characterized by accelerated growth, 
development of secondary sexual characteristics, and psychological 
changes (Buck Louis et al. 2008). Menarche, the first menstrual period, is 
a prominent event in the sexual maturation of adolescent girls. The 
timing of onset of puberty, including age at menarche, is of public health 
interest due to its association with a wide range of adverse health out-
comes in later life. The studies have reported various cancers, cardio- 
metabolic, gynecological, and neurocognitive disease in later life (Day 
et al. 2015). Several factors are associated with the onset of puberty, 
such as nutrition, health conditions, genetics, and exposure to envi-
ronmental toxicants (Canelon and Boland 2020; Morris et al. 2011; 
Villamor and Jansen 2016). Epidemiological studies have increasingly 
reported associations between exposure to certain naturally occurring 
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metals and chemical compounds and several reproductive endpoints, 
including age at menarche (Chalupka and Chalupka 2010). 
Arsenic contamination in groundwater exists in many parts of the 
world. Millions worldwide, particularly in Bangladesh, are exposed to 
arsenic mainly through drinking water from tube wells. The high con-
tent of arsenic in tube wells in Bangladesh probably originates from 
Ganges’ delta fine alluvial sediments (Ahmad et al. 2018). Based on 
adverse health consequences of arsenic exposure, the World Health 
Organization (WHO) issued a provisional guideline value for arsenic 
drinking water less than 10 µg/L (National Research Council 2001; 
Smith et al. 2000; WHO 1993). However, Bangladesh continues to 
follow the previous WHO guideline value of 50 µg arsenic/L in drinking 
water as an acceptable level (WHO 1984). Studies have reported asso-
ciations between arsenic exposure and increased risk of a wide range of 
diseases and conditions, including skin lesions (Rahman et al. 2006), 
cardiovascular (Moon et al. 2012; Rahman 2002) and respiratory dis-
eases (Milton and Rahman 2002) and lung function (von Ehrenstein 
et al. 2005), type-2 diabetes (Navas-Acien et al. 2006), and malignancies 
of skin and internal organs (International Agency for Research on Cancer 
2004). 
Arsenic can easily pass through the placenta and poses a threat to 
early human development (Concha et al., 1998a). Previous studies have 
reported that prenatal arsenic exposure was associated with adverse 
pregnancy outcomes, including spontaneous abortion (Milton et al. 
2005; Rahman et al. 2007), stillbirth (Milton et al. 2005; von Ehrenstein 
et al. 2006) and low birthweight (Rahman et al. 2009). Other studies 
have reported associations between prenatal arsenic exposure and 
children’s neurocognitive development (Hamadani et al. 2011; Tolins 
et al. 2014; Vahter et al. 2020; von Ehrenstein et al. 2007), and in some 
studies, these associations have been reported to more pronounced in 
girls than in boys (Hamadani et al. 2011; Vahter et al. 2020). 
Animal studies have indicated an association between arsenic 
exposure and endocrine disruption and altered sexual maturation 
(Davey et al. 2007; Davey et al. 2008; Davila-Esqueda et al. 2012; Kal-
treider et al. 2001; Reilly et al. 2014). In contrast to the studies that 
reported delay in sexual maturation (Davila-Esqueda et al. 2012; Reilly 
et al. 2014), two studies conducted on female mice (Li et al. 2018; 
Rodriguez et al. 2016) reported early onset of puberty. While the 
possible roles of arsenic exposure on pubertal development in animal 
models have been increasingly published, the knowledge regarding the 
possible impact of arsenic exposure on the timing of pubertal develop-
ment, including age at menarche, in girls in arsenic-affected areas is 
limited. So far, only two ecological studies have suggested that age at 
menarche was delayed when exposed to high arsenic levels (Sen and 
Chaudhuri 2007; Sengupta 2004). The first study evaluated 385 girls 
aged 15–20 years living in arsenic (>50 µg/L) and non-arsenic affected 
areas. The study observed that the mean age of menarche was 14.0 and 
13.3 years in girls from areas of high (>50 µg/L) and low concentrations 
of arsenic in tube well water, respectively (Sengupta 2004). The second 
study evaluated 280 girls from four villages where water arsenic con-
centrations varied from 10 to 600 µg/L and 70 girls from a control 
village with arsenic concentrations in tube well water ranged from 10 to 
300 µg/L. The study has reported the mean age at menarche 12.5 and 
11.7 years in arsenic affected and control villages, respectively (Sen and 
Chaudhuri 2007). The studies had some limitations in exposure and 
outcome assessments. 
No studies have previously addressed this research question based on 
prospectively collected information and individual arsenic exposure 
data. Therefore, we aimed to study the association between individual 
prenatal arsenic exposure and age at menarche in adolescent girls in a 
well-characterized cohort with a follow-up from birth to puberty in 
Matlab, Bangladesh. 
2. Subjects and Methods 
2.1. Study site 
We conducted this study in Matlab Upazila, a sub-district under 
Chandpur, Bangladesh, located 55 km southeast of the capital Dhaka. 
This area is one of the most arsenic-affected regions in Bangladesh. 
About 70% of tube wells had arsenic concentrations exceeding the WHO 
guideline value of 10 µg/L (Rahman et al. 2006). The International 
Center for Diarrhoeal Disease Research, Bangladesh (icddr,b) has been 
running a Health and Demographic Surveillance System (HDSS) in 
Matlab since 1966. In the HDSS area, Community Health Research 
Workers collect information on vital events such as marriage, birth, 
death, and migration by monthly home visits. The present study was 
conducted in half of the HDSS area, covering a population of about 
110,000, in which icddr,b provides health services to women of repro-
ductive age and their children up to five years of age. The study area is 
divided into four administrative blocks, and each block has a sub-center 
that provides primary obstetric and child health care through the 
paramedical staff. The sub-centers are linked to the Matlab Hospital, 
which provides maternal and child health services by nursing staff su-
pervised by medical officers. 
2.2. Study design and participants 
The study was based on data from two research projects conducted in 
the HDSS area – the Maternal and Infant Nutrition Interventions in 
Matlab (MINIMat) trial (isrctn.org identifier: ISRCTN16581394) and the 
Health Consequences of Arsenic in Matlab (AsMat) study. The MINIMat 
trial enrolled pregnant women from November 2001 to October 2003 
and randomly allocated them into different food and micronutrient 
supplementation groups to evaluate birth outcomes and child survival 
(Persson et al. 2012). The mother–child cohort of the MINIMat trial has 
been prospectively followed for a wide range of assessments. In the 
present study, we included the children who participated in the follow- 
up for evaluating growth and pubertal development, including infor-
mation on the occurrence and age at menarche of participating girls 
from July 2016 to Jun 2017. In the cross-sectional AsMat study, con-
ducted from January 2002 to August 2003, all household members were 
interviewed regarding lifetime drinking water sources used by the study 
participants, combined with the collection of tube well water samples to 
assess the individual arsenic exposure. The household is a unique 
structure within a ’bari’ where all the members eat from the same 
cooking pot. A ’bari’ is a cluster of households using a common court-
yard. Each household usually installs a tube well for washing and 
drinking purposes. However, a household from a low socioeconomic 
group may not afford a tube well. In those instances, the members may 
use water from tube wells of neighboring households. The details of 
study procedures in the MINIMat (Arifeen et al. 2018) and the AsMat 
(Rahman et al. 2006) studies have been presented elsewhere. In the 
present analysis, girls in the MINIMat cohort who participated in 
assessing age at menarche and where information on their mothers’ 
drinking water sources was available from the AsMat databases were 
eligible for analysis. 
2.3. Exposure assessment 
The individual prenatal arsenic exposure of MINIMat girls was based 
on arsenic concentration in the tube well water used by their mothers 
during pregnancy. Using the unique registration number from the HDSS, 
we extracted information on the tube well water used by the MINIMat 
women during their pregnancy from the AsMat databases. In the AsMat 
study, an independent team visited all households in the HDSS area to 
provide a unique identification number to all active tube wells. Teams of 
field workers collected information on lifetime drinking water sources 
and duration of uses of those sources for all inhabitants above the age of 
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four years in the study area by moving from household to household and 
interviewing the family members. A follow-up team subsequently visited 
already interviewed households to collect water samples from all func-
tioning tube wells. All the above activities enabled the construction of 
chronological years of consumption of arsenic in the study participants’ 
drinking water. The total arsenic concentration in water was measured 
by hydride generation atomic absorption spectrophotometry (model 
AA6800 spectrophotometer; Shimadzu Corporation, Kyoto, Japan) at 
the icddr,b laboratory (Vahter et al. 2006). The limit of detection (LOD) 
was 1 µg/L, and samples with values below LOD were assigned a value of 
LOD/2. 
2.4. Outcome assessment 
The outcome of the study was the age at menarche. Information on 
pubertal development was collected on two occasions, six months apart, 
to increase the validity of reported menarcheal age data collection. The 
first assessment was conducted from July 2016 to January 2017, and the 
second one from January 2017 to June 2017. All participants who took 
part in the first follow up were also invited for a second follow up visit 
after about six months. We used the age at menarche data collected in 
the second follow-up visit. However, for girls who did not participate in 
the second follow up, we used the information from the first follow up 
visit. If the information on age (date) at menarche differed between the 
first and the second follow-up, we used the information collected closer 
to the event (i.e., the first visit). Data on menarche were collected by 
asking the girls whether or not they had had their menstruation. If the 
girl had menstruation already, the exact day, month and year of the first 
menstruation were assessed by a recall. The interviewers used a local 
events calendar if needed. If the girl did not recall the exact day, the 15th 
of the month was imputed. Subsequently, the age at menarche was 
calculated by analyzing the exact time between the birth date from the 
MINIMat database and the first menstruation date. If the girl had not had 
her first menstruation, the follow-up was censored at the date of the 
second visit or the first visit when the girls did not reappear for the 
second assessment. 
2.5. Covariates 
Covariate information was obtained from the MINIMat databases 
that captured the mother’s physical and socio-demographic data at 
pregnancy, delivery, and follow-up of the girls at 4.5 and 12–15 years of 
age. Maternal weight and height were assessed at first clinic visits in the 
sub-center during enrollment, usually around gestational week eight, 
using SECA, Uniscale, Hamburg, Germany (precision 100 g), and a 
locally made wooden scale (precision 0.1 cm). The mothers’ body mass 
index (BMI) was calculated as weight (kg)/height (m)2. Birthweight and 
birth length were collected using an electronic scale (SECA, Hamburg, 
Germany, precision 10 g) and a collapsible locally made length board 
(precision 0.1 cm), respectively. At birth, gestational age was calculated 
by subtracting the last menstrual period date, collected monthly by 
community health research workers, from the infant’s delivery date. 
Information on maternal age, parity, and achieved educational level was 
obtained from the HDSS databases. Maternal education was expressed as 
the number of years in formal schooling. Socioeconomic status, defined 
as an asset score, was analyzed through principal component analysis 
based on the collected household asset ownership, including land 
possession and housing structures. We obtained children’s height data 
from follow-up databases at 12–15 years of age to determine the height- 
for-age Z-score (HAZ) and subsequent categorization to stunted (<-2 Z- 
score) and not-stunted (≥-2 Z-score) children. Furthermore, we used the 
MINIMat intervention (different nutrition supplementations) as a co-
variate in the analysis. The MINIMat intervention groups were: sup-
plementation of 30 mg iron and 400 µg of folic acid, 60 mg iron and 400 
µg of folic acid or multiple micronutrients, including 30 mg iron and 
400 µg of folic acid, combined with early (around nine gestation weeks) 
or late (around 20 gestation weeks) daily food supplementation (Arifeen 
et al. 2018; Persson et al. 2012). 
2.6. Statistical analysis 
Data were presented as means, medians, and proportions. Kaplan- 
Meier survival analysis was used to assess the median age at 
menarche. Associations between covariates (mother’s age, BMI, parity, 
education, socioeconomic status, children’s birthweight, height-for-age 
at 12–15 years, and supplementation group) and outcomes were 
assessed by log-rank test. Non-parametric tests determined associations 
between covariates and arsenic exposure. The covariates associated with 
arsenic exposure and outcome were identified as potential confounders 
and included in the final multivariable-adjusted model. The girls’ pre-
natal arsenic exposure was expressed as water arsenic concentration 
measured in the tube well water used by the mothers during pregnancy. 
The exposure was categorized into levels <10, 10–49, 50–99, 100–199, 
and ≥200 µg/L. The categorization was done based on an earlier study in 
the same study area (Sohel et al. 2009) and easy interpretation of the 
problem’s magnitude by policymakers. We also dichotomized the ex-
posures according to Bangladesh’s drinking water guidelines (<50 µg/L 
and ≥50 µg/L). Furthermore, due to a low number of girls in the cate-
gories between 10 and 200 µg/L, we assessed the risk by dividing the 
tube well arsenic concentrations into tertiles. 
The association between arsenic exposure and age at menarche was 
evaluated by Cox proportional hazards model, including potential con-
founding factors. We used robust cluster errors in the regression analysis 
to estimate risks to account for multiple users of a tube well. We also 
performed the analysis limited to tube wells that were only used by one 
pregnant woman. The effect estimates were presented as adjusted haz-
ards ratio (aHR) and 95% confidence intervals (CI). Date of birth was 
assigned as time = 0, and follow-up was censored if the outcome of 
interest (occurrence of menarche) had not happened at the interview 
date of the second follow up visit or at the first visit date of the girls who 
did not reappear for assessment. We used Stata version 13 for all sta-
tistical analyses (StataCorp, College Station, TX, USA). 
3. Results 
3.1. Participant selection 
Out of the total of 4436 pregnant women enrolled in the MINIMat 
trial from February 2002 to January 2003, 3625 had live births, whereof 
3560 were singletons. A total of 2307 children (1175 girls and 1132 
boys) were followed up at 12–15 years of age. Out of the total girls who 
completed the pubertal follow-up, 809 had arsenic exposure information 
during the prenatal period and were included in the analysis (Fig. 1). All 
participants included in the analysis attended the first follow up, how-
ever, 770 girls reappeared in the second visit. 
3.2. Characteristics of study girls and their mothers 
The characteristics of pregnant women and their children enrolled in 
the MINIMat study are presented in Table 1. The mean (±SD) age of 
women at delivery was 26.7 (±6) years, and 37% were less than 25 years 
old. The mean weight and height of the women measured at 8 weeks of 
gestation were 45 (±6.7) kg and 150 (±5) cm, respectively, and 29% of 
women were underweight (BMI < 18.5 kg/m2). The mean birthweight 
and gestational age at delivery of study girls were 2671 (±365) g and 
39.5(±1.5) weeks, respectively. During the first and second pubertal 
follow-up, the mean and median (minimum, maximum) ages were 13.2 
(±0.45), 13.2 (12.4, 14.2) and 13.8 (±0.46), 13.7(12.9, 14.7) years, 
respectively. 
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3.3. Arsenic exposure and age at menarche, and their associations with 
covariates 
The distributions of arsenic exposures are presented in Table 2. The 
median and mean arsenic concentrations in tube well water consumed 
by the pregnant women were 80 µg/L and 156 µg/L (±178), respec-
tively. About 55% of the women were drinking tube well water with 
arsenic concentrations above Bangladesh’s acceptable value of 50 µg/L. 
About 16.8% of tube wells were used by more than one mother, and 2% 
(n = 15) changed tube well during pregnancy. 
Out of 809 girls, 39 (4.8%) did not appear in the second visit. Four 
girls did not report menarche occurrence at first visits and did not 
appear for the second assessment. All girls were able to report the year 
and month of menarche if it had happened. However, 245 (49%) girls 
could not report the exact day of the first menstruation. Table 3 presents 
the distribution of age at menarche of adolescent girls. The median age 
at menarche was 13.0 (95% CI: 12.9–13.1) years. About 61% and 76.4% 
of girls had reached menarche during the first and second follow-up 
visits, respectively. The median (minimum, maximum) recall period 
between menarche and data collection was 0.5 (0, 3.3) years. 
Table 4 presents the associations of selected maternal and child 
characteristics with age at menarche and the corresponding median 
prenatal arsenic exposure. Maternal education, household asset scores, 
and maternal BMI were identified as potential confounders (Table 4) and 
thus adjusted for in the multivariable-adjusted model. 
Pregnant women randomized 
(N=4,436) 
Pregnant women randomized  
(N=4,436) 
845 Lost to follow up 
• Pregnancy loss (n = 436) 
• Withdrawal consents (n = 129) 
• Migrated out (n= 183) 
• Others (n = 92) 
Women giving birth (n=3591) 
Total live births (n=3625) 
(3560 singletons, 65 multiple) 
825 Lost to follow up 
• Under-five deaths (n = 161) 
• Migrated out (n = 448) 
• Refused or unavailable (n= 216) 
Assessed at 4.5 years 
(n=2800) 
493 Lost to follow up 
• Death (n= 3) 
• Migrated out (n = 131) 
• Refused or unavailable (n= 359) 
Assessed at 12-15 years 
(n = 2307) 
1132 adolescent boys 
Adolescent girls 
 (n=1,175) 
366 girls no arsenic exposure data 
• Nonfunctioning tube wells 
• Used water from tube well water 
outside study area 
Adolescent girls with prenatal arsenic 
exposure data 
 (n = 809) 
Fig. 1. Study profile.  
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3.4. Associations between arsenic exposure and age at menarche 
The girls’ prenatal arsenic exposure was associated with their age at 
menarche (Fig. 2). Age at menarche of girls with prenatal arsenic 
exposure ≥200 µg/L was delayed by 3.2 months compared to girls with 
prenatal arsenic exposure <10 µg/L in the unadjusted analysis (Fig. 2, 
Table 5). Girls exposed to the same high arsenic level in the prenatal 
period were 23% (aHR 0.77, 95% CI: 0.63–0.95) less likely to have 
Table1 
Characteristics of mothers and the adolescent girls participated in the follow up 






Maternal characteristics No. % No. % P-value 
Age at birth of infants(years)      
<25 300 37.1 199 54.4 <0.001 
25–34 416 51.4 147 40.2  
≥35 93 11.5 20 5.5  
Parity      
0 166 20.5 149 40.7 <0.001 
1–2 458 56.7 164 44.8  
≥3 184 22.8 53 14.5  
Body mass index(kg/m2) at 8 weeks of 
gestation      
<18.5 234 29.0 111 30.5 0.0182 
18.5–24.9 529 65.6 242 66.5  
≥25 44 5.4 11 3.0  
Mother’s education (years)      
0 285 35.2 121 33.1 0.258 
1–5 213 26.3 86 23.5  
>5 311 38.5 159 43.4  
Wealth scores in tertile      
1 290 35.8 142 38.8 0.431 
2 274 33.9 126 34.4  
3 245 30.3 98 26.8  
Girls’ characteristics      
Birthweight (g)      
<2500 257 31.8 146 39.9 0.007 
≥2500 552 68.2 220 60.1  
Gestational age at birth (weeks)      
<37 43 5.3 26 7.1 0.227 
≥37 766 94.7 340 92.9  
Education (years in school)      
<6 35 4.5  6.7 0.135 
≥6 739 95.5 322 93.3  
Height-for-age Z –score at puberty      
Not stunted (≥− 2) 667 82.5 276 76.2 0.011 
Stunted (<− 2) 141 17.5 687 23.8   
Table 2 
The concentrations of arsenic in tube well water consumed by mothers of 
adolescent girls during pregnancy.  
Arsenic level (μg/L) Pregnancy Arsenic concentration, group 
median ((μg/L)  
No. %  
<10 280 34.6 0.5 
10–49 86 10.6 23.0 
50–99 46 5.7 68.1 
100–199 106 13.1 158.3 
≥200 291 36.0 327.6 
Arsenic levels in μg/L by tertiles 
(minimum, maximum)    
1 (0.5, 7.8) 269 33.2 0.5 
2 (7.9, 216) 270 33.4 76.9 
3 (216.5,1014.7) 270 33.4 338.0  
Table 3 
Frequency distribution of reported age at menarche of adolescent girls in Mat-
lab, Bangladesh (n = 809).  
Age Frequency of menarche Percentage Cumulative percentage 
9.0–9.9 1 0.12 0.12 
10.0–10.9 14 1.73 1.85 
11.0–11.9 115 14.22 16.07 
12.0–12.9 277 34.24 50.31 
13.0–13.9 198 24.47 74.78 
14.0–14.9 13 1.61 76.39  
Table 4 
Associations of selected maternal and girls’ characteristics with age at menarche 
and prenatal arsenic exposure in Matlab, Bangladesh.   
Number Age at 
menarche in 
years  








Age at birth of infants 
(years)      
<25 300 13.3 <0.001 67 0.211 
25–34 416 13.0  111  
≥35 93 12.7  53  
Parity      
0 166 12.8  46 0.681 
1–2 458 13.0  103  
≥3 184 13.1  76  
Education (years)      
0 285 13.2 <0.001 157 0.002 
1–5 213 13.1  53  
>5 311 12.7  49  
Wealth score in 
tertiles      
1 (poorer) 290 13.2 <0.001 185 <0.001 
2 (medium) 274 13.1  68  
3 (richer) 245 12.6  26  
Body mass index (kg/ 
m2) at gestational 
week 8      
<18.5 234 13.1 <0.001 142 0.002 
18.5–24.9 529 13.0  92  
≥25 44 12.5  15  
Prenatal 
supplementation 
groupsc      
1 124 13.0 0.580 111 0.714 
2 151 12.8  111  
3 138 12.9  68  
4 147 13.0  108  
5 122 13.0  70  
6 127 13.1  70  
Girls’ characteristics      
Birthweight (g)      
<2500 257 13.0 0.826 102 0.860 
>=2500 552 13.0  76  
Education at pubertal 
follow up (years in 
school)      
<6 35 12.9 0.387 102 1.0 
≥6 739 13.0  88  
Height-for-age Z- 
score at 12–15 
years      
Not stunted (≥− 2) 667 12.8 <0.001 92 0.501 
Stunted (<− 2) 141 13.7  52  
Age at pubertal 
follow up (years)      
<14 759 13.0 0.097 83 0.683 
≥14 51 13.1  105   
a by log-rank test. 
b by median test. 
c supplementation groups: 1 = early food + 30 mg iron and 400 µg of folic 
acid, 2 = early food + 30 mg iron and 400 µg of folic acid, 3 = early food +
multiple micronutrient , 4 = late food + 30 mg iron and 400 µg of folic acid, 5 =
late food + 60 mg iron and 400 µg of folic acid, 6 late food + multiple 
micronutrient. 
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reached menarche than girls exposed to low arsenic levels. When the 
analysis was limited to tube well users by single study participants, the 
likelihood of reaching menarche was similar (aHR 0.73, 95% CI: 
0.59–0.89) in the high exposure group (≥200 µg/L) (Table 5). Exposure 
above Bangladesh’s acceptable level of arsenic (≥50 µg/L) implied 2.8 
months delay in the timing of menarche, and the aHR of 0.84 (95% CI: 
0.70–0.99) compared with the girls who had exposure to arsenic below 
the accepted level (<50 µg/L) in drinking water. 
Furthermore, when we included stunting of adolescent girls at first 
follow up visit as a covariate, the aHRs were 0.77 (95% CI: 0.57–1.06), 
0.81 (95% CI: 0.53–1.25), 0.78 (95% CI 0.61–1.01), 
and 0.74 (95% CI: 0.61–0.90) in the 10–49, 50–99, 100–199 and 
≥200 µg/L arsenic concentration groups in drinking water, respectively, 
compared with the group in < 10 µg/L. Using the two water sources’ 
averages for the 15 women who changed the tube well in pregnancy, we 
did not observe any change in the effect estimates (data not shown). The 
aHRs were 0.82 (95% CI: 0.66–0.1.03) and 0.75 (95% CI: 0.60–0.93) in 
the group second and third tertiles of arsenic exposures, respectively, 
compared with the group exposed in the first tertile. 
4. Discussion 
Pubertal development, including age at menarche, is a significant 
public health issue due to its implications for future health and well-
being. In this prospective cohort study, we evaluated the associations of 
individual arsenic exposure in intrauterine life with age at menarche in 
the offspring for the first time. We report that early life arsenic exposure 
was associated with later age at menarche. Girls exposed to ≥200 µg 
arsenic/L were 23% less likely to have reached menarche at the time of 
follow-up than girls with arsenic concentrations below the WHO 
guideline value of 10 µg arsenic/L in water. A categorization according 
to Bangladesh’s acceptable value of 50 µg arsenic/L in drinking water 
yielded similar results. Girls exposed to higher concentrations were 16% 
less likely to have reached menarche at the time of follow-up than those 
exposed to lower concentrations. 
No previous epidemiological studies with individual exposure data 
have evaluated the association between early-life arsenic exposure and 
age at menarche. Two ecological studies from West Bengal, India, sug-
gested such associations when comparing age at menarche in different 
villages with different arsenic levels in drinking water (Sen and 
Chaudhuri 2007; Sengupta 2004). Further, those studies lacked suffi-
cient information on how the age at menarche was assessed. Although 
we measured individual water arsenic concentrations from tube wells, 
we observed that more than one woman used 16.8% of tube wells during 
pregnancy. We used robust clustered standard errors for estimating the 
risk in the regression model to address the issue of multiple users of a 
tube well. Furthermore, we did not find any change in effect estimation 
when the analysis was restricted to tube wells used by a single woman. 
For better exposure assessment, future studies should consider using 
urine arsenic concentrations or other biomarkers to capture individual 
exposure from drinking water and food (Hughes 2006). 
The possible mechanisms of how arsenic may influence pubertal 
development in humans have so far not been studied. Experimental 
animal studies have documented that arsenic at low doses acts as an 
endocrine disruptor, possibly through an estrogenic mode of action 
(Bodwell et al. 2004; Davey et al. 2008; Jana et al. 2006; Kaltreider et al. 
2001). Estrogen is a sex steroid, and menarche is mainly related to es-
trogen levels (Apter 1980; Apter and Vihko 1985). A study on rats 
showed that arsenic interacted with estrogenic receptors and suppressed 
estrogen synthesis (Chattopadhyay et al. 1999). In another study on rats 
with pre- and postnatal arsenic exposure, the estrogen levels were 
decreased, and like in the present study, pubertal development was 
delayed (Davila-Esqueda et al. 2012). Another study that exposed rats to 
arsenic during early development after births suggested that pubertal 
delay was linked to suppression of insulin-like growth factor-1 (IGF-1) 
(Reilly et al. 2014). In contrast to the studies mentioned above, two 
relatively new studies reported the early onset of puberty in mice 
exposed to arsenic during prenatal periods. (Li et al. 2018; Rodriguez 
et al. 2016). This early onset was suggested because of increased levels 
of luteinizing hormone or other factors, including mRNA and protein 
expression of the puberty related genes and glucose intolerance. 
The present study has several strengths. The analyses were based on 
a well-characterized cohort of pregnant women with follow-up of the 
offspring on several occasions before assessing pubertal development on 
two occasions at 12–15 years of age. The loss to follow up was reason-
ably low, despite a long duration of cohort follow-up. Besides, compared 
to the background characteristics between the group included in the 
analysis and those not included due to missing arsenic exposure data, we 
did not observe any differences in potential confounders, including 
maternal education and socioeconomic status by asset tertiles and 
maternal body mass index. The fact that the assessment of the menarche 
outcome was performed without any prior knowledge of the arsenic- 
related research question decreased the risk of information bias. 
The exposure in utero was assessed by the arsenic concentration in 
drinking water used by the adolescent girls’ mothers during pregnancy. 
Arsenic in tube well water most likely captured the exposure levels 
efficiently as all women stayed in the study area during pregnancy and 
Fig. 2. Cumulative proportions of menarche by age for different prenatal 
arsenic exposure levels (μg arsenic/L in drinking water) in Matlab, Bangladesh. 
Table 5 
Association between prenatal arsenic exposure, assessed by arsenic concentrations in tube well water used by mothers, and age at menarche of girls in Matlab, 
Bangladesh.  
Water arsenic concentration interval 
(median) in μg/L 










<10 (0.5) 281 224 12.8 1  1  
10–49 (22) 86 62 12.9 0.80 0.60–1.06 0.82 0.59–1.14 
50–99 (68) 46 34 12.8 0.87 0.60 –1.24 0.89 0.58–1.36 
100–199 (158) 106 82 13.1 0.79 0.61–1.01 0.82 0.64–1.05 
200–1014 (328) 290 216 13.1 0.72 0.59–0.87 0.77 0.63–0.95  
a Events indicate the menarche had taken place. 
b Adjusted for maternal socioeconomic status, education, and body mass index. 
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used tube well water from the same source. In the present study, about 
two-thirds of participants fell into the lowest and the highest arsenic 
categories and the remaining one-third belonged to the three middle 
categories. This distribution was consistent with our previous studies in 
the same area (Rahman et al. 2007; Rahman et al. 2006). Very few of 
these women (2%) changed water sources during pregnancy. When 
checking the potential influence of this change, we did not observe any 
differences in effect estimates. The lack of information on water arsenic 
exposure during early childhood is a limitation. This implies that the 
observed association reflects the exposure of the mother-and-child dyad 
from pregnancy and onwards. The arsenic exposure through drinking 
water may continue when the child starts to drink tube well water. Thus, 
the relative strength of the association may have been influenced by this 
lack of information on the child’s arsenic exposure. Earlier studies have 
reported that very small amounts of arsenic pass through breast milk 
(Concha et al. 1998b). Our study area findings confirmed this, showing 
that urinary arsenic concentrations measured at three months were 
substantially lower than the mother’s urinary arsenic concentrations 
(Fangstrom et al. 2008), particularly in the exclusively breastfed group. 
It should be noted that exclusive breastfeeding practices among the 
MINIMat children were relatively high, with 50% of infants exclusively 
breastfed up to six months (Eneroth et al. 2009) and most continuing 
partial breastfeeding to two years and beyond (Saha et al. 2008). This 
population may also be exposed to arsenic from other sources, particu-
larly from food (Kippler et al. 2016), and this additional exposure was 
probably most likely randomly distributed. We did not assess concurrent 
arsenic exposure in adolescent girls. However, the literature suggests 
that the critical windows of vulnerability to toxic exposures are during 
prenatal and early childhood (Braun 2017; Gluckman et al. 2008). 
The reliability of reported age at menarche may be questioned. A 
menarche is a significant event in a young woman’s life, which is not 
easily forgotten, also in the Bangladesh culture. Data on age at menarche 
were collected by recall using a local events calendar when needed. The 
recall period, i.e., the time between the interview and date of menarche, 
may influence the validity of the assessment. In our study, the median 
recall period was about 0.5 years, which is substantially lower than 
other studies. If the date of menarche differed between the first and the 
second follow-up, we used the information collected closer to the event 
(i.e., the first visit). In addition, we have the exact birth date information 
of the study participants. 
The median age of menarche in the present study was 13 years, 
which is similar to estimates from many high-income countries (Harris 
et al. 2008; Parent et al. 2003). This similarity is surprising, considering 
the Bangladeshi girls’ socioeconomic and nutritional background 
compared to those in affluent societies. However, our finding is also in 
concordance with other Bangladeshi studies conducted in 1996 and 
2009 reporting a median age at menarche of 13.0 years and 12.8 years, 
respectively (Chowdhury et al. 2000; Rah et al. 2009). The distribution 
of menarche attainment by ages in our study was also found similar to 
Bangladesh’s study (Chowdhury et al. 2000). 
5. Conclusions 
We have shown that an increased level of prenatal arsenic exposures 
was associated with a delay in age at menarche in adolescent girls in a 
rural area in Bangladesh. This delay may indicate endocrine disruption 
that potentially could impair reproductive health systems, including 
pubertal development. Endocrine-disruptive toxins may imply risk for 
other adverse health outcomes, including impaired neurodevelopment, 
thyroid function, and increases in hormone-sensitive cancers in later life 
(WHO 2013). Due to the lack of biomarker data we cannot link bio-
logical factors related to the observed delay in the present study. Future 
human studies are needed to study the role of arsenic exposures in 
perturbation of the neuroendocrine systems and impairment of other 
reproductive endpoints. The observed delay in age at menarche in this 
study, possibly through endocrine disruption, reinforces the need to 
mitigate arsenic contamination at the population level. 
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